Rule 1: Molecules with a presence of sulfur, specifically in a sulfonamide group, may have potential side effects on pregnancy, puerperium, and perinatal conditions due to its antimicrobial property and teratogenic effects when taken during pregnancy.

Rule 2: Molecules containing metal ions such as calcium, sodium, or iodine can pose risks to pregnancy, puerperium, and perinatal conditions and should be cautiously used.

Rule 3: Presence of halogen atoms like chlorine or fluorine in the molecular structure may increase the risk of birth defects if taken during pregnancy as these elements can cross the placenta and affect fetal development.

Rule 4: Molecules with functional groups like "C=O" or "C#N" can cause potential side effects related to pregnancy, puerperium, and perinatal conditions as these groups are common in drugs known to cause adverse reactions during pregnancy.

Rule 5: Molecules with a sulfonyl group (SO2R) may have potential side effects related to pregnancy, puerperium, and perinatal conditions as some drugs containing sulfonyl groups are known to cross the placenta and affect fetal development.

Rule 6: Molecules containing a sulfonamide group (-SO2NH-) or a nitro group (-NO2) can have potential side effects during pregnancy, puerperium, and perinatal conditions due to their ability to cross the placenta and affect fetal development.

Rule 7: Usage of compounds having a quinazoline ring system during pregnancy must be carefully evaluated as they can act as antagonists for various receptors involved in reproductive functions, posing potential side effects.

Rule 8: Compounds with a halogen atom attached to an aromatic ring can disrupt hormonal balance by potentially interacting with estrogen receptors and should be avoided during pregnancy.

Rule 9: Molecules with a chlorine atom bonded to a carbon atom adjacent to a carbonyl group may have potential side effects related to pregnancy, puerperium, and perinatal conditions.

Rule 10: Molecules containing a nitrogen-containing ring structure, specifically a pyrimidine ring (-C4H4N2-) or a pyridine ring (-C5H5N-), may have potential side effects related to pregnancy, puerperium, and perinatal conditions.

Rule 11: Molecules with a sulfhydryl group (-SH) or a disulfide bond (-SS-) can negatively affect reactivity and binding ability and can potentially have side effects during pregnancy, puerperium, and perinatal conditions. 

Rule 12: Molecules containing iodine atoms may disrupt thyroid function and lead to developmental abnormalities, hence these molecules have potential side effects during pregnancy, puerperium, and perinatal conditions.

Rule 13: The presence of functional groups such as "-COOH" or "-CHO" in a molecule can affect the pH balance of the body during pregnancy, hence potentially causing side effects.

Rule 14: A molecule containing nitro group (-NO2) conjugated with an alkene or alkyne group may have potential side effects related to pregnancy, puerperium, and perinatal conditions.

Rule 15: Potential side effects related to pregnancy, puerperium, and perinatal conditions can be encountered if a molecule has a nitrile group (-CN) adjacent to an aromatic ring.

Rule 16: Molecules containing a carbonyl group (C=O) connected to an aromatic ring through a double bond can potentially cause side effects on pregnancy, puerperium, and perinatal conditions.

Rule 17: Molecules with a high degree of conjugation, i.e., multiple double bonds or aromatic rings connected together, can be potentially harmful during pregnancy, puerperium, and perinatal conditions due to their increased reactivity towards other molecules.

Rule 18: Molecules containing fluorine atoms are generally considered safe during pregnancy but more research is needed to fully understand the impact of fluorinated compounds on maternal and fetal health. 

Rule 19: Molecules with a halogen atom, such as chlorine or fluorine, bonded to an aromatic ring may be less likely to have side effects on pregnancy, puerperium, and perinatal conditions.

Rule 20: Molecules containing compounds with a nitro group (-NO2) attached to an aromatic ring may have potential side effects on pregnancy, puerperium, and perinatal conditions due to their toxicity and potential to cause DNA damage.
Rule 1: If a molecule contains a functional group called isocyanate (-N=C=O), nitroso (-NO) or carboxylic acid (-COOH), it may potentially cause side effects related to pregnancy, puerperium, and perinatal conditions. 
Rule 2: Molecules containing a sulfonamide group (-SO2NH-), a nitro group (-NO2), a halogen atom (chlorine or fluorine), or nitrogen-containing heterocyclic ring structures might result in potential side effects during pregnancy, puerperium, or perinatal conditions. 
Rule 3: If a molecule contains a chlorine atom bonded to a carbon atom, a conjugated system of double bonds between carbon atoms, or a negatively charged oxygen atom bonded to two carbon atoms, it could potentially lead to risk during pregnancy, puerperium, and perinatal periods. 
Rule 4: Molecules that contain structures like a chlorine atom bonded to a carbon atom in a six-membered ring structure, a triple bond, or a nitrogen atom could have potential risks when used during pregnancy, puerperium, or perinatal conditions.
Rule 5: Compounds with nitro group (-NO2) attached to an aromatic ring, a chlorine atom bonded to an aromatic ring, or a carbonyl group (-C=O) adjacent to an aromatic ring may be dangerous during pregnancy, puerperium, or perinatal conditions.
Rule 6: If a molecule contains functional groups such as -COOH or -OH, aromatic rings, and nitrogen atoms, they could lead to potential adverse effects during pregnancy, puerperium, and perinatal period.
Rule 7: If a molecule contains a chlorine atom attached to a carbon atom bonded to two oxygen atoms, or a nitrogen atom bonded to four carbon atoms in a chain, there may be potential side effects during pregnancy, puerperium, and perinatal conditions.
Rule 8: Molecules with a phosphate group, a fluorine atom attached to a carbon atom in a cyclopropane ring, or a nitrogen atom bonded to a carbonyl group could be harmful during pregnancy, puerperium, and perinatal phase.
Rule 9: Molecules containing the substructure "C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-]" or "CC(C(=O)N1C2CCCCC2CC1C(=O)O)NC(CCC3=CC=CC=C3)C(=O)O" may have potential side effects on pregnancy, puerperium, and perinatal conditions.
Rule 10: If a molecule contains sulfonamide group (-SO2NH-), a nitro group (-NO2), cyano group (-CN) or a halogen atom, it could cause side effects during pregnancy, puerperium, and perinatal conditions.
Rule 11: If a molecular structure contains functional groups like "-COOR" or "-COOH", their presence can lead to potential side effects during pregnancy, puerperium, and perinatal periods.
Rule 12: Based on the dataset, the presence of a benzene ring, a disulfide bond, or a conjugated ketone group in the structure of a molecule can potentially lead to side effects during pregnancy, puerperium, and perinatal periods.
Rule 13: If a molecule contains the substructure "CCCC(=O)O", "NC1=NN=C(C2=C1C(=C(S2)C3=NC(=Nc=c3)C)SS3)C4=CC=CC=C4F" or "C1=CNN=C(C2=C1C(=C(S2)C3=NC(=Nc=n3)C)SSC3)C4=CC=CC=C4F", it may potentially cause side effects during pregnancy, puerperium, and perinatal conditions.
Rule 14: If a molecule contains structures like a sulfonamide group (-SO2NH-) or a nitro group (-NO2), a cyano group (-CN) attached to a carbon atom adjacent to a carbonyl group (-C=O), or a halogen atom, it could have potential side effects during pregnancy, puerperium, and perinatal period.
Rule 15: If a molecule contains a functional group such as "-COOR" or "-COOH", a benzene ring, or a long carbon chain, then it may have potential side effects related to pregnancy, puerperium, and perinatal periods.
Rule 16: If a molecule contains substructures such as "CCOC(=O)C1=CNN2C(=O)C(C(=O)O)C12" or "CC(C)(C)Nc1cnc(ncc1Oc2ccc(cc2Br)I)N", then it could result in potential side effects during pregnancy, puerperium, and perinatal phases.
Rule 1: If sulfur is present in the molecular structure, the compound may potentially cause side effects on pregnancy, puerperium, and perinatal conditions.
Rule 2: Presence of a sulfonamide group (-SO2NH-) or similar functional group in a compound may lead to potential side effects during pregnancy, puerperium, and perinatal conditions.
Rule 3: Compounds containing halogen atoms like chlorine (Cl) or fluorine (F) on their aromatic rings may pose risks during pregnancy, puerperium, and perinatal conditions.
Rule 4: If a compound has a negatively charged oxygen atom bonded to two carbon atoms (-C=O-), it could potentially cause adverse reactions.
Rule 5: If a compound contains a functional group such as "-COOH" or "-OH", it may impact pregnancy, puerperium, and perinatal conditions.
Rule 6: Compounds with a conjugated system consisting of multiple double bonds may be associated with negative health outcomes for pregnant women.
Rule 7: A compound with a nitro group (-NO2) may pose a risk to fetal development if taken during pregnancy.
Rule 8: Compounds containing a functional group called "sulfide" or "disulfide" may have potential side effects related to pregnancy, puerperium, and perinatal conditions.
Rule 9: If a molecule contains a halogen atom such as chlorine or bromine, it could potentially have pregnancy-related side effects.
Rule 10: Molecules with a conjugated system of double bonds, such as a benzene ring or a chain of alternating single and double bonds, may also have potential side effects related to pregnancy, puerperium, and perinatal conditions.
Rule 11: Molecules containing a functional group called "ketone" or "aldehyde" in conjugation with another double bond may have potential side effects related to pregnancy, puerperium, and perinatal conditions.
Rule 12: Molecules containing a sulfonyl group (SO2R) may also have potential pregnancy-related side effects.
Rule 13: Presence of functional groups like phosphate or carboxylate ions in a compound may increase the potential for causing adverse effects during pregnancy, puerperium, and perinatal conditions.
Rule 14: Compounds with conjugated double bonds or aromatic rings may have a higher risk of causing adverse effects during pregnancy, puerperium, and perinatal conditions.
